caffeine has been researched along with dihydroergotoxine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rand, MJ; Roberts, G | 1 |
| Jones, RS; Olpe, HR; Steinmann, MW | 1 |
| Migeon, P; Poncin-Lafitte, M; Rancurel, G; Rapin, JR | 1 |
| Ballard, SA; Chasseaud, LF; Down, WH | 1 |
| Ardouin, T; Delhotal Landes, B; Ezan, E; Flouvat, B; Grognet, JM; Hanslik, T; Legeai, JM | 1 |
| Burdukovskaia, NL; Molokov, DD; Shprakh, VV; Tatarinova, MB | 1 |
| Sadekov, RA | 1 |
| Grinshteĭn, AB; Kromm, OK; Pavlovskaia, MV; Shnaĭder, NA | 1 |
| LUGARESI, E; REBUCCI, GG | 1 |
| HART, JA; HUDGSON, P | 1 |
| LECHAT, P; MAGET, E; STREICHENBERGER, G | 1 |
| Zaĭtseva, IN | 1 |
| Azimova, IuE; Tabeeva, GR | 1 |
| Kamchatnov, PR | 2 |
| Barantsevich, ER; Belskaya, GN; Kopishinskaya, SV; Levin, OS; Lukashevich, IG; Ostroumova, OD; Psokhina, OV; Radiuk, MA; Vasenina, EE | 1 |
2 trial(s) available for caffeine and dihydroergotoxine
| Article | Year |
|---|---|
[The use of vasobral in patients with chronic cerebrovascular disorders].
Topics: Adult; Aged; Caffeine; Cerebrovascular Disorders; Chronic Disease; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome | 2011 |
[Efficacy of the combination drug vasobral in chronic vascular encephalopathy].
Topics: Adult; Aged; Brain Damage, Chronic; Brain Ischemia; Caffeine; Cerebral Small Vessel Diseases; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Treatment Outcome | 2014 |
14 other study(ies) available for caffeine and dihydroergotoxine
| Article | Year |
|---|---|
Chromosomal damage induced by some ergot derivatives in vitro.
Topics: Caffeine; Cells, Cultured; Chromosome Aberrations; Chromosomes; Dihydroergotoxine; Dose-Response Relationship, Drug; Ergot Alkaloids; Ergotamine; Humans; Lymphocytes; Methysergide | 1977 |
Locus coeruleus as a target for psychogeriatric agents.
Topics: Amphetamine; Animals; Caffeine; Cerebral Cortex; Dihydroergotoxine; Dose-Response Relationship, Drug; Learning; Locus Coeruleus; Male; Memory; Methylphenidate; Neural Pathways; Neurons; Piracetam; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Septum Pellucidum; Vincamine | 1985 |
[Vasobral and stabilized cerebral vascular complication: hemodynamic and psychometric study].
Topics: Aged; Brain Ischemia; Caffeine; Cerebrovascular Circulation; Dihydroergotoxine; Drug Combinations; Humans; Middle Aged; Psychometrics | 1987 |
The effect of caffeine on the absorption of 3H-dihydroergocryptine (DHEC) in the rat.
Topics: Animals; Caffeine; Dihydroergotoxine; Intestinal Absorption; Male; Rats; Time Factors | 1980 |
Bioequivalence study of alpha-dihydroergocryptine: utility of metabolite evaluation.
Topics: Adrenergic alpha-Antagonists; Adult; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Dihydroergotoxine; Humans; Male; Therapeutic Equivalency | 1996 |
[Vasobral in the treatment of initial atherosclerotic circulatory encephalopathy].
Topics: Adult; Aged; Caffeine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Female; Humans; Intracranial Arteriosclerosis; Male; Middle Aged | 1996 |
[The influence of alpha-dihydroergocryptine derivatives on psychomotor manifestations in Parkinson disease].
Topics: Antiparkinson Agents; Caffeine; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Memory; Middle Aged; Parkinson Disease; Psychomotor Performance; Treatment Outcome | 2000 |
[Experience in the administration of vasobral in sensorineural vascular hypoasusis].
Topics: Administration, Oral; Adult; Caffeine; Dihydroergotoxine; Drug Administration Schedule; Drug Combinations; Hearing Loss, Sensorineural; Humans; Neuroprotective Agents; Osteochondritis; Retrospective Studies; Vertebrobasilar Insufficiency | 2001 |
[Preliminary research on the action of some drugs in the light of cerebral and peripheral contemporaneous rheographic registrations].
Topics: Acetylcholine; Blood Circulation; Caffeine; Cerebral Arteries; Dihydroergotoxine; Epinephrine; Ergot Alkaloids; Norepinephrine; Papaverine; Plethysmography, Impedance; Sympatholytics; Tolazoline | 1962 |
ACUTE ERGOTISM: REPORT OF A CSE AND A REVIEW OF THE LITERATURE.
Topics: Anesthesia; Anesthesia, Conduction; Anesthesiology; Autonomic Nerve Block; Caffeine; Cardiovascular Agents; Dihydroergotoxine; Ergot Alkaloids; Ergotamine; Ergotism; Gastric Lavage; Humans; Neurologic Manifestations; Penicillins; Tolazoline; Toxicology; Vasodilator Agents | 1964 |
[PHARMACOLOGIC STUDY OF RETURN TO SLEEP INDUCED IN THE RAT BY SUDDEN CHANGE IN ENVIRONMENTAL TEMPERATURE].
Topics: Adrenalectomy; Amphetamine; Amphetamines; Caffeine; Chloral Hydrate; Cocaine; Dihydroergotoxine; Ergot Alkaloids; Hexobarbital; Hypnotics and Sedatives; Iproniazid; Pentobarbital; Pentylenetetrazole; Pharmacology; Pregnanediones; Rats; Research; Reserpine; Sleep; Temperature; Yohimbine | 1965 |
[Use of vasobral in therapy of central nervous system pathology in children of early age].
Topics: Administration, Oral; Caffeine; Central Nervous System Diseases; Child, Preschool; Dihydroergotoxine; Dose-Response Relationship, Drug; Drug Combinations; Follow-Up Studies; Humans; Infant; Psychomotor Performance; Treatment Outcome | 2010 |
[Preventive treatment of migraine with vasobral: a multicenter trial].
Topics: Adolescent; Adult; Aged; Caffeine; Dihydroergotoxine; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
[Vasobral in the treatment of brain lesions: views of physicians and patients].
Topics: Caffeine; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dihydroergotoxine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Memory; Patients; Physicians; Surveys and Questionnaires; Vertigo | 2013 |